In human renal cells, it has been demonstrated that EGF promotes EMT by offsetting the pro-apoptotic effects of TGFβ1 without preventing its EMT-inducing effect, thereby facilitating the improved survival of cells undergoing EMT [27], in concordance with our results of EGFR activated human BC cells. This evidence concerns the gene TGFB1 and breast cancer.